Rates and Patterns of Clonal Oncogenic Mutations in the Normal Human Brain
Related Experiment Video
Updated: Oct 24, 2025

Lineage Tracing and Clonal Analysis in Developing Cerebral Cortex Using Mosaic Analysis with Double Markers MADM
Published on: May 8, 2020
Javier Ganz1,2,3,4,5, Eduardo A Maury1,2,3,4,5,6, Basheer Becerra1,2,3,4,5
1Division of Genetics and Genomics, Manton Center for Orphan Disease, Boston Children's Hospital, Boston, Massachusetts.
Abstract:
Although oncogenic mutations have been found in nondiseased, proliferative nonneural tissues, their prevalence in the human brain is unknown. Targeted sequencing of genes implicated in brain tumors in 418 samples derived from 110 individuals of varying ages, without tumor diagnoses, detected oncogenic somatic single-nucleotide variants (sSNV) in 5.4% of the brains, including IDH1 R132H. These mutations were largely present in subcortical white matter and enriched in glial cells and, surprisingly, were less common in older individuals. A depletion of high-allele frequency sSNVs representing macroscopic clones with age was replicated by analysis of bulk RNA sequencing data from 1,816 nondiseased brain samples ranging from fetal to old age. We also describe large clonal copy number variants and that sSNVs show mutational signatures resembling those found in gliomas, suggesting that mutational processes of the normal brain drive early glial oncogenesis. This study helps understand the origin and early evolution of brain tumors. SIGNIFICANCE: In the nondiseased brain, clonal oncogenic mutations are enriched in white matter and are less common in older individuals. We revealed early steps in acquiring oncogenic variants, which are essential to understanding brain tumor origins and building new mutational baselines for diagnostics.This article is highlighted in the In This Issue feature, p. 1.
Insights
Oncogenic mutations, including IDH1, were found in 5.4% of non-diseased human brains, particularly in white matter and glial cells. These brain mutations were less common in older individuals, offering insights into early brain tumor development.
Area of Science:
- Neuroscience
- Genetics
- Oncology
Background:
- Oncogenic mutations are known in non-neural tissues but their prevalence in the human brain is unclear.
- Understanding these mutations is crucial for deciphering brain tumor origins.
Purpose of the Study:
- To investigate the prevalence and characteristics of oncogenic somatic single-nucleotide variants (sSNVs) in the non-diseased human brain.
- To explore the relationship between these mutations, age, and brain cell types.
Main Methods:
- Targeted sequencing of 418 brain samples from 110 individuals.
- Analysis of bulk RNA sequencing data from 1,816 non-diseased brain samples.
- Examination of clonal copy number variants and mutational signatures.
Main Results:
- Oncogenic sSNVs were detected in 5.4% of brains, including IDH1R132H.
- Mutations were enriched in subcortical white matter and glial cells.
- sSNVs were less common in older individuals, with a depletion of high-allele frequency variants.
Conclusions:
- The normal brain harbors oncogenic mutations that resemble those found in gliomas, suggesting a role in early oncogenesis.
- These findings provide insights into the origin and early evolution of brain tumors.
- Establishing mutational baselines in the non-diseased brain is essential for diagnostics.
Related Concept Videos
Neuron Structure
Structure and Function of Neurons
The neuronal cell body—the soma— houses the nucleus and organelles vital to...
Cancers Originate from Somatic Mutations in a Single Cell

